Aldatu Biosciences is the leader in adaptive PCR diagnostics for global health and emerging diseases.
Aldatu Biosciences has raised $3.0M in total funding. The most recent round was Grant. The last funding was announced in August 2024.
Aldatu Biosciences's investors include MassChallenge, National Institutes of Health, Massachusetts Life Sciences Center, Springhood, National Institute of Allergy and Infectious Diseases.
Aldatu Biosciences is headquartered in Watertown, United States.
Aldatu Biosciences is the leader in adaptive PCR diagnostics for global health and emerging diseases.
Aldatu Biosciences is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Aldatu Biosciences — Funding & Investors." VCBacked, August 1, 2024, https://www.vcbacked.co/company/aldatu-biosciences. Accessed July 19, 2026.
VCBacked. (2024). Aldatu Biosciences — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/aldatu-biosciences
{{cite web |title=Aldatu Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/aldatu-biosciences |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated